Rubric Capital Management (New York)’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $94.7M | Buy |
11,710,332
+974,355
| +9% | +$7.88M | 1.43% | 18 |
|
|
2025
Q1 | $90M | Buy |
10,735,977
+14,199
| +0.1% | +$119K | 1.61% | 18 |
|
|
2024
Q4 | $84.9M | Hold |
10,721,778
| – | – | 1.09% | 16 |
|
|
2024
Q3 | $89.2M | Hold |
10,721,778
| – | – | 1.45% | 14 |
|
|
2024
Q2 | $68.1M | Buy |
10,721,778
+1,179,830
| +12% | +$7.49M | 1.79% | 18 |
|
|
2024
Q1 | $57.8M | Buy |
9,541,948
+1,541,948
| +19% | +$9.34M | 1.71% | 22 |
|
|
2023
Q4 | $48.6M | Buy |
8,000,000
+3,975,500
| +99% | +$24.1M | 1.01% | 23 |
|
|
2023
Q3 | $17M | Buy |
4,024,500
+1,423,121
| +55% | +$6.01M | 0.64% | 37 |
|
|
2023
Q2 | $8.06M | Buy |
+2,601,379
| New | +$8.06M | 0.34% | 50 |
|